Edhyana Sahiratmadja

Dr. Edhyana Sahiratmadja


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2007 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
BABachti Alisjahbana
Bachti Alisjahbana
ESEdhyana Sahiratmadja
Edhyana Sahiratmadja
ENErni J. Nelwan
Erni J. Nelwan
APAnugrah Maya Purwa
Anugrah Maya Purwa
YAYana Ahmad
Yana Ahmad
RCR. V. Crevel
R. V. Crevel
Background.Diabetes mellitus (DM) is a known risk factor for tuberculosis (TB), and with the increasing prevalence of type 2 DM in less developed reg

21 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TOTom H M Ottenhoff
Tom H M Ottenhoff
RDRanjeeta Hari Dass
Ranjeeta Hari Dass
NYNinghan Yang
Ninghan Yang
MZMingzi Zhang
Mingzi Zhang
HWHazel E E Wong
Hazel E E Wong
MHMartin Hibberd
Martin Hibberd
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M.tb), remains the leading cause of mortality from a single infectious agent. Each year around 9 million individuals newly develop active TB disease, and over 2 billion individuals are latently infected with M.tb worldwide, thus being at risk of developing TB reactivation disease later in life. The underlying mechanisms and pathways of protection against TB in humans, as well as the dynamics of the host response to M.tb infection, are incompletely understood. We carried out whole-genome expression profiling on a cohort of TB patients longitudinally sampled along 3 time-points: during active infection, during treatment, and after completion of curative treatment. We identified molecular signatures involving the upregulation of type-1 interferon (α/β) mediated signaling and chronic inflammation during active TB disease in an Indonesian population, in line with results from two recent studies in ethnically and epidemiologically different populations in Europe and South Africa. Expression profiles were captured in neutrophil-depleted blood samples, indicating a major contribution of lymphocytes and myeloid cells. Expression of type-1 interferon (α/β) genes mediated was also upregulated in the lungs of M.tb infected mice and in infected human macrophages. In patients, the regulated gene expression-signature normalized during treatment, including the type-1 interferon mediated signaling and a concurrent opposite regulation of interferon-gamma. Further analysis revealed IL15RA, UBE2L6 and GBP4 as molecules involved in the type-I interferon response in all three experimental models. Our data is highly suggestive that the innate immune type-I interferon signaling cascade could be used as a quantitative tool for monitoring active TB disease, and provide evidence that components of the patient’s blood gene expression signature bear similarities to the pulmonary and macrophage response to mycobacterial infection.

5 February 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TTThorsten Thye
Thorsten Thye
EOEllis Owusu-Dabo
Ellis Owusu-Dabo
FVFredrik O Vannberg
Fredrik O Vannberg
RCReinout van Crevel
Reinout van Crevel
JCJames Curtis
James Curtis
CMChristian G Meyer
Christian G Meyer

10 October 2008 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
SDSonia Davila
Sonia Davila
MHMartin Hibberd
Martin Hibberd
RDRanjeeta Hari Dass
Ranjeeta Hari Dass
HWHazel E E Wong
Hazel E E Wong
ESEdhyana Sahiratmadja
Edhyana Sahiratmadja
MSMark Seielstad
Mark Seielstad
Despite high rates of exposure, only 5–10% of people infected with Mycobacterium tuberculosis will develop active tuberculosis (TB) disease, suggesting a significant role for genetic variation in the human immune response to this infection. Here, we studied TB association and expression of 18 genes involved in the Toll-like receptor (TLR) pathways. Initially, we genotyped 149 sequence polymorphisms in 375 pulmonary TB patients and 387 controls from Indonesia. We found that four polymorphisms in the TLR8 gene on chromosome X showed evidence of association with TB susceptibility in males, including a non-synonymous polymorphism rs3764880 (Met1Val; P = 0.007, odds ratio (OR) = 1.8, 95% c.i. = 1.2–2.7). We genotyped these four TLR8 polymorphisms in an independent collection of 1,837 pulmonary TB patients and 1,779 controls from Russia and again found evidence of association in males (for rs3764880 P = 0.03, OR = 1.2, 95% c.i. = 1.02–1.48). Combined evidence for association is P = 1.2×10−3–6×10−4. In addition, a quantitative PCR analysis indicated that TLR8 transcript levels are significantly up-regulated in patients during the acute phase of disease (P = 9.36×10−5), relative to baseline levels following successful chemotherapy. A marked increase in TLR8 protein expression was also observed directly in differentiated macrophages upon infection with M. bovis bacille Calmette-Guérin (BCG). Taken together, our results provide evidence, for the first time, of a role for the TLR8 gene in susceptibility to pulmonary TB across different populations. One third of the world population is infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis; however, only 5–10% of those infected will develop active disease. Difference in polymorphisms within genes involved in host immune response has been proposed as a plausible reason to explain this phenomenon. Here, we show genetic association of four polymorphisms of TLR8, a member of a well-known receptor family involved in pathogen recognition, in an Indonesian population. The association was replicated in males of a follow up cohort from Russia. Expression levels of TLR8 transcripts and protein showed a marked increase during bacterial infection, confirming our initial findings. To our knowledge, this is the first time that TLR8 has been associated with response to M. tuberculosis. Our results suggest that it may play a significant role in tuberculosis susceptibility and disease activity, and thus should be the focus of concerted studies in human systems.

1 February 2007 in Infection and Immunity
Verified
Journal Article
Closed access
ESEdhyana Sahiratmadja
Edhyana Sahiratmadja
BABachti Alisjahbana
Bachti Alisjahbana
TBTjitske de Boer
Tjitske de Boer
IAIskandar Adnan
Iskandar Adnan
AMAnugrah Maya
Anugrah Maya
TOTom H. M. Ottenhoff
Tom H. M. Ottenhoff
Pro- and anti-inflammatory cytokines and their signaling pathways play key roles in protection from and pathogenesis of mycobacterial infection, and their balance and dynamic changes may control or predict clinical outcome. Peripheral blood cells' capacity to produce proinflammatory (tumor necrosis factor alpha [TNF-α], interleukin-12/23p40 [IL-12/23p40], and gamma interferon [IFN-γ]) and anti-inflammatory (IL-10) cytokines in response toMycobacterium tuberculosisor unrelated stimuli (lipopolysaccharide, phytohemagglutinin) was studied in 93 pulmonary tuberculosis (TB) patients and 127 healthy controls from Indonesia. Their cells' ability to respond to IFN-γ was examined to investigate whetherM. tuberculosisinfection can also inhibit IFN-γ receptor (IFN-γR) signaling. Although there was interindividual variability in the observed responses, the overall results revealed thatM. tuberculosis-induced TNF-α and IFN-γ levels showed opposite trends. Whereas TNF-α production was higher in active-TB patients than in controls, IFN-γ production was strongly depressed during active TB, correlated inversely with TB disease severity, and increased during therapy. By contrast, mitogen-induced IFN-γ production, although lower in patients than in controls, did not change during treatment, suggesting anM. tuberculosis-specific and reversible component in the depression of IFN-γ. Depressed IFN-γ production was not due to decreased IL-12/IL-23 production. Importantly, IFN-γ-inducible responses were also significantly depressed during active TB and normalized during treatment, revealing disease activity-related and reversible impairment in IFN-γR signaling in TB. Finally, IFN-γ/IL-10 ratios significantly correlated with TB cure. Taken together, these results show thatM. tuberculosis-specific stimulation of IFN-γ (but not TNF-α) production and IFN-γR signaling are significantly depressed in active TB, correlate with TB disease severity and activity, and normalize during microbiological TB cure. The depression of both IFN-γ production and IFN-γR signaling may synergize in contributing to defective host control in active TB.

13 January 2012 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
EPEileen Png
Eileen Png
BABachti Alisjahbana
Bachti Alisjahbana
ESEdhyana Sahiratmadja
Edhyana Sahiratmadja
SMSangkot Marzuki
Sangkot Marzuki
RNRon Nelwan
Ron Nelwan
MSMark Seielstad
Mark Seielstad
There is reason to expect strong genetic influences on the risk of developing active pulmonary tuberculosis (TB) among latently infected individuals. Many of the genome wide linkage and association studies (GWAS) to date have been conducted on African populations. In order to identify additional targets in genetically dissimilar populations, and to enhance our understanding of this disease, we performed a multi-stage GWAS in a Southeast Asian cohort from Indonesia.